(1)
The Efficacy of Certolizumab Pegol Re-Treatment on Plaque Psoriasis Following a Blinded Treatment Break: Results from the CIMPACT Trial. J of Skin 2019, 3 (2), 174. https://doi.org/10.25251/skin.3.2.14.